Minoxidil 5mg + Finasteride 1mg Tablets

Product Information

The Evidence

A 2025 UK retrospective study followed 502 men using a combined oral minoxidil-finasteride regimen for 12 months and found 92.4% achieved stable or improved hair density, with 57.4% showing marked improvement. The study also noted that baseline hair-loss severity (Norwood stage) influenced the size of the improvement, with earlier-stage patients generally seeing better outcomes. This builds on decades of separate evidence for each drug individually — finasteride for slowing DHT-driven hair loss, and minoxidil for stimulating regrowth — with real-world data increasingly supporting the combination as more effective and convenient than either drug alone.

Who Shouldn't Take This

• Women — finasteride is not approved for use in women, especially those who are or may become pregnant, due to risk of birth defects in male fetuses from even brief exposure
• Men with a history of depression or significant mood changes — require closer monitoring while on finasteride
• Men with cardiovascular conditions — oral minoxidil requires blood pressure monitoring even at low doses
• Anyone with known hypersensitivity to either active ingredient

References

1. Johnson H, et al. — Effectiveness of Combined Oral Minoxidil and Finasteride in Male Androgenetic Alopecia: A Retrospective Service Evaluation, Cureus 2025
2. GoodRx — Can You Combine Finasteride and Minoxidil for Hair Loss?
3. NHS — About Finasteride (referenced via Cureus study, 2023)

Medically reviewed. Last updated: [20/06/2026]. This content is for informational purposes and does not replace consultation with a licensed physician.

How it works

Finasteride blocks 5-alpha-reductase, the enzyme that converts testosterone into DHT — the hormone responsible for shrinking hair follicles in male pattern baldness — while minoxidil widens blood vessels and opens potassium channels to increase blood flow to the scalp and extend the hair growth (anagen) phase. Because the two drugs work on different parts of the hair-loss process, combining them addresses both the cause (DHT) and the follicle environment (blood flow), which is why combination therapy is increasingly preferred over either drug alone.

Minoxidil 5mg + Finasteride 1mg is a once-daily oral combination treatment for male pattern hair loss (androgenetic alopecia), pairing two drugs with different mechanisms: finasteride blocks the hormone (DHT) that causes follicle shrinkage, while minoxidil increases scalp blood flow to stimulate regrowth. This combination is for men only and is not suitable for women, particularly those who are or may become pregnant. A 12-month UK retrospective study of 502 men using a similar oral minoxidil-finasteride combination found 92.4% achieved stable or improved hair density, with 57.4% showing marked improvement.

Storage

Store at 15–30°C, away from sunlight and moisture. Keep out of reach of children and away from women who are or may become pregnant — finasteride tablets should not be handled by pregnant women, even when intact.

The most commonly reported side effects are mild and include temporary increased shedding in the first 2–3 months, scalp or facial hair changes, and rare sexual side effects associated with finasteride.

• Initial shedding: some men experience temporary increased shedding in the first 2–3 months as follicles transition into a healthier growth cycle — this is expected, not a sign of treatment failure
• Sexual side effects: finasteride has been associated with libido or sexual function changes in a small percentage of men; report any persistent changes to your doctor
• Mood changes: rare reports of mood or depressive symptoms with finasteride; men with a prior history should be monitored closely
• Hypertrichosis: mild increase in fine facial or body hair from the minoxidil component
• Blood pressure changes: periodic monitoring is recommended for the minoxidil component